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The fate of patients with retinal artery occlusion
and Hollenhorst plaque
Allan B. Dunlap, MD,a Gregory S. Kosmorsky, DO,b and Vikram S. Kashyap, MD,a Cleveland, Ohio
Objective: Ocular symptoms and signs often herald hemispheric neurological events associated with extracranial cerebro-
vascular disease. However, the presence of a Hollenhorst plaque (HP) or retinal artery occlusion (RAO) and the risk of
stroke is unclear. The purpose of this study was to review the outcomes of all patients who presented with a HP or RAO
at a single institution.
Methods: Between 2000 and 2005, the management and outcome of 130 consecutive patients with a diagnosis of HP,
central RAO, or branch RAO (ICD-9 codes 362.30 to 362.33) were reviewed. Patients with transient monocular visual
loss (amaurosis fugax), retinal venous occlusion, and other ocular pathologies were excluded. Electronic and hardcopy
medical records were reviewed for demographic data, clinical variables, radiological, and noninvasive vascular lab testing.
Duplex and magnetic resonance angiography (MRA) of the carotid arteries were reviewed to confirm the presence of a
lesion and quantify the degree of stenosis.
Results: During the study interval, 70 males and 60 females, with a mean age of 68  16 (SD) years underwent
ophthalmologic evaluation. Symptoms were present in 61% of patients and included eye pain, blurred vision, or atypical
visual symptoms, while 39% were asymptomatic. Atherosclerotic risk factors in this population included the presence of
hypertension (73%), diabetes (33%), hyperlipidemia (75%), and tobacco use (38%). A majority of patients underwent
carotid interrogation via Duplex imaging (68%). Carotid bifurcation stenoses ipsilateral to the ocular findings were<30%
in 68% of the patients, between 30 and 60% in 22% and>60% in only 8% of patients. Six patients with lesions greater than
60% went on to have either a carotid endarterectomy or carotid stenting. Follow-up data on this group ranged from 1 to
49 months (median, 22 months), with no stroke or transient ischemic attack identified. There were five deaths during
follow-up; none related to stroke. Serial carotid Duplex examinations failed to identify progression of carotid stenoses in
this group of patients. Overall survival was 94% at 36 months for this cohort.
Conclusion: The presence of a HP or RAO is associated with a low prevalence of extracranial cerebrovascular disease that
requires intervention. Furthermore, in contradistinction to amaurosis fugax, these ocular findings are not associated with
a high risk for hemispheric neurological events. ( J Vasc Surg 2007;46:1125-9.)Hollenhorst first described the embolization of choles-
terol crystals to the retinal circulation in 1958.1 Subsequent
reports indicated that these retinal emboli were associated
with carotid atherosclerosis, visual loss, and strokes.2 Con-
sequently, the identification of a Hollenhorst plaque (HP,
Fig 1) or retinal artery occlusion (RAO) has led to concern
for associated cerebrovascular disease and hemispheric neu-
rological events.
Carotid endarterectomy (CEA) has been established by
several large, prospective, randomized trials as a safe and
effective intervention for reduction of stroke risk in symp-
tomatic patients with significant carotid stenosis.3,4 Cur-
rently, there is a paucity of data on the natural history of
patients presenting with either HP or RAO. The dilemma
remains whether to apply data from symptomatic carotid
trials to the management of patients with these ocular
findings. Our goal was to review the outcome of all patients
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and assess if these findings heralded future stroke.
METHODS
After Institutional Review Board (IRB) approval, a
retrospective review was performed of patients at the Cleve-
land Clinic Foundation with a diagnosis of HP, central
RAO or branch RAO (ICD-9 codes 362.30 to 362.33). A
total of 130 patients treated from 2000 to 2005 formed the
basis for this study. The following diagnoses were excluded:
transient monocular visual loss (amaurosis fugax, ICD-9
code 362.34), retinal venous occlusion (362.35 to
362.37), and other ocular conditions including optic neu-
ropathy, retinopathy, and chronic ocular ischemia. Demo-
graphic data and risk factors were collected including age,
smoking history, diabetes mellitus, hypertension, renal fail-
ure (serum Cr 3.0 mg/dL), and hyperlipidemia from
electronic and hard copy medical records. Additional labo-
ratory data, including hypercoagulable testing obtained in
selected cases, were recorded. All radiological imaging and
noninvasive vascular laboratory testing were reviewed. All
duplex studies of the carotid arteries were reviewed via
captured and stored electronic images (MagicView x-ray
program) to confirm the presence of a lesion and quantify
the degree of stenoses. Duplex examinations were per-
formed in Intersocietal Commission for the Accreditation
of Vascular Laboratories (ICAVL) accredited laboratories.
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spectral analysis. Given the slightly different stratification
reporting in the laboratories performing Duplex, patients
were grouped as 30%, 30% to 60%, and 60% for sim-
plicity. All clinical, perioperative, and demographic data
were obtained through review of original hospital, and
physician records including data collected prospectively in a
departmental registry.
For statistical analyses, a P value of less than .05 was
considered significant. Life table analyses were performed
to calculate survival and stroke-free survival curves. Interval
of follow-up at the Cleveland Clinic Foundation was re-
corded (median 22 months, range 1 to 49 months).
RESULTS
Patient demographic and clinical factors are displayed
in Table I. Patients were considered to have hypertension,
diabetes mellitus, hyperlipidemia, or coronary artery dis-
ease on patient history or treatment history for each disease
process. Patients were considered to have renal failure if
they had a serum creatinine greater than 3.0 mg/dL or
were on chronic dialysis. Atherosclerotic risk factors in this
population included the presence of hypertension (73%),
diabetes (33%), hyperlipidemia (75%), coronary artery dis-
ease (59%), and tobacco use (38%). This represented a
similar risk profile when compared with patients with ex-
tracranial cerebrovascular disease at our institution.5 We
found five patients in this cohort with hypercoagulable
states; including two patients with lupus anticoagulant and
two with anticardiolipin antibodies. Six patients (5%) car-
ried a diagnosis of previous cerebrovascular accident. Fur-
thermore, six patients carried the diagnosis of giant cell
arteritis, and one patient had lupus. Lastly, there were five
Fig 1. Hollenhorst plaque. Note the bright yellow cholesterol
embolus lodged at the retinal artery bifurcation.patients with documented patent foramen ovale or septaldefect and four patients with atrial fibrillation (9/130
patients, 7%).
During the study interval, 70 males and 60 females,
with a mean age of 68 16 (SD) years underwent ophthal-
mologic evaluation. In 80 patients (61%), evaluation was
performed for eye pain, blurred vision, partial vision loss/
field defect, or atypical visual symptoms. None of these
patients had transient monocular blindness consistent with
amaurosis fugax. Of the patients presenting with eye symp-
toms or visual complaints, 68 had unilateral symptoms vs
12 with bilateral symptoms. Of those with unilateral symp-
toms, there was a two to one preponderance of left sided vs
right sided symptoms.
Fifty patients (39%) were asymptomatic and had no
visual complaints. These individuals had RAO or HP diag-
nosed on fundoscopic examination. When looking at the
retinal lesions of all 130 patients, there were 95 patients
with HP (37 patients with retinal examinations performed
at outside institutions), 34 patients with branch RAO, and
one patient with central RAO. Again, there was a prepon-
derance of left sided lesions. HP were found 48% of the
time on the left, 41% on the right, and 11% bilaterally. The
RAO were 47% left, 38% right, and 15% bilateral.
The vast majority of patients were referred to the vas-
cular laboratory and underwent carotid interrogation via
Duplex imaging (n 88, 68%). Carotid bifurcation lesions
ipsilateral to the ocular findings were 30% in 70% of the
patients undergoing Duplex, between 30% and 60% in 22%
and 60% in only 8% of patients (Table II). Six of the eight
patients with lesions greater than 60% went on to have
either a CEA (n  4) or carotid stenting (n  2). This
group included four females and two males. All six patients
had critical carotid artery stenosis (80%) and underwent
surgery or stenting without perioperative complications.
The remaining two patients were managed medically for a
moderate (60%) carotid stenosis in one patient and severe
comorbidities precluding operative therapy in the other.
Echocardiographic studies were performed in approxi-
mately 20% of patients in order to identify a more proximal
Table I. Demographics and clinical factors in patients
presenting with retinal artery occlusion or
Hollenohorst plaque
N  130 %
Mean age 68  16 y
Male 70 54%
Hypertension 95 73%
Diabetes 43 33%
Hyperlipidemia 98 75%
Coronary artery disease 77 59%
Tobacco use* 50 38%
Renal failure 0 0%
Hypercoagulable state 5 4%
Previous CVA 6 5%
CVA, Cerebrovascular accident.
*Both current and previous users.source of arterial embolization. Despite findings of minor
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aortic arch source for the retinal findings and none under-
went long-term anticoagulation. Also, aortic or carotid
dissection was not found in any patient in this series.
Follow-up data ranged from 1 to 49 months (median
22 months). In this cohort, 71 patients (55%) had at least
one follow-up carotid Duplex study performed within the
first 3months. Furthermore, 12% had two and 6% had three
or more serial noninvasive examinations. Serial Duplex
examinations failed to identify progression of carotid ste-
nosis in this group of patients (mean Duplex interval, 9
months). In follow-up, no stroke or transient ischemic
attack was identified in these 130 patients. There were five
deaths; none related to stroke. Two patients died of cardiac
disease; one after myocardial infarction and the other from
congestive heart failure. Two patients succumbed to cancer
(small cell-lung and ovarian). One patient died after com-
plications from a hip fracture. Stroke-free survival and
overall survival were equivalent at 94% at 3 years in this
cohort (Fig 2).
DISCUSSION
Vascular surgeons often see patients presenting with
eye symptoms with a concern for extracranial carotid occlu-
sive disease. Implicit in the referral of these patients is that
an arterial embolus from the carotid bifurcation is leading
to embolic ischemic damage to the eye, and that this may be
a harbinger of future ipsilateral hemispheric events. The eye
symptoms generally fall into the four categories of transient
monocular visual loss (TMVL, ie, amaurosis fugax),
chronic ocular ischemia, RAO, and HP. The latter two are
the subject of this article.
The treatment of patients with symptomatic severe
carotid atherosclerosis has been documented. In the North
American Symptomatic Carotid Endarterectomy Trial
(NASCET), patients with TMVL, transient ischemic attack
or nondisabling stroke, and severe carotid bifurcation ste-
nosis were randomized to either CEA or medical manage-
ment.3 Surgical management led to a 2-year ipsilateral
stroke rate of 9% vs 26% for patients undergoing medical
management alone (P .001). However, subsequent anal-
yses showed the rate of stroke to be less in patients present-
ing with TMVL vs hemispheric ischemia.6 Still, patients
presenting with TMVL have a 17% 2-year stroke rate and a
1% to 2% yearly rate of permanent blindness secondary to
retinal stroke.7 Chronic ocular ischemia is another well-
Table II. Carotid bifurcation stenoses by duplex
ipsilateral to ocular findings
Stenosis % N  98* %
30% 68 70%
30% to 60% 22 22%
60% 8 8%
*98 carotid bifurcations in 88 patients; 10 patients with bilateral ocular
findings.described entity in which retinal metabolic demand is notmet by the blood supply leading to visual deterioration.
Despite being much less common an entity than TMVL,
surgical management of carotid occlusive disease in the
setting of chronic ocular ischemia has led to gratifying
improvement in visual function.8,9
Hollenhorst’s description of bright plaques in the ret-
ina implicated cholesterol crystal embolization from ulcer-
ated proximal atherosclerotic lesions.2 Further data linking
HP to critical carotid stenosis was described by Chawluk
and colleagues.10 Patients with HP were more likely to have
a stenotic or ulcerated carotid plaque than patients with
TMVL (P .04). Kirshner et al reviewed 131 cases of
cerebrovascular disease with ocular manifestations that un-
derwent CEA.11 Visual symptoms were mostly in the form
of TMVL. However, in 20 patients, permanent visual loss
was secondary to RAO. Despite correction of the ipsilateral
carotid stenosis, patients presenting with permanent visual
loss had no restoration of visual function. Five cases of
permanent visual loss secondary to RAO were preceded by
multiple episodes of TMVL. These reports taken together
suggested that cholesterol emboli to the eye are herald
signs of embolizing carotid bifurcation atheroma and fur-
ther ipsilateral hemispheric neurological damage may
ensue.
Over time, this view has undergone modification. Bunt
studied 60 patients with visual symptoms and evaluated all
with cerebral angiography.12 Of the 60 patients, 18 pa-
tients had asymptomatic HP found on ocular examination.
Half of these patients had ipsilateral carotid bifurcation
disease, but only five of the 18 required CEA. None of the
patients presenting with HP developed cerebral symptoms.
In contradistinction, 26 patients with amaurosis fugax had
a 70% incidence of carotid bifurcation disease with 50%
requiring CEA. Bunt concluded that HP alone was a poor
predictor of future embolic events to either the retina or the
carotid circulation.12 Of interest, sequential fundoscopic
examination found persistence ofHP in five of nine patients
for over a year. This indicated that the incidental finding of
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Fig 2. Overall survival rate. Overall survival was 94% at 36
months (SE 10%). There were five deaths during this interval,
but none related to strokes. Patients at risk: time 0 130 patients;
12 months  80 patients; 24 months  58 patients; and 36
months  32 patients.HP could represent an embolic event from long ago. Sim-
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28 patients underwent CEA for corresponding ipsilateral
carotid stenosis.13 Despite correction of stenoses, four pa-
tients developed new ipsilateral HP and two late strokes
occurred. They concluded that CEA in patients with
asymptomatic HP did not prevent the development of new
HP or late cerebrovascular events.
McCullough et al examined 105 patients presenting
with TMVL (26%), and HP (19%), while the majority of
patients (55%) had other symptoms including anterior isch-
emic optic neuropathy, optic atrophy, and venous occlu-
sion.14 The finding of a positive carotid scan (50% to 60%
stenosis) was low for both TMVL (20%) and HP (18%)
with poor predictive value. All other ocular findings, except
venous stasis retinopathy, had no predictive value in iden-
tifying carotid occlusive disease. They concluded that ocu-
lar symptoms and findings at fundoscopic examination
were generally poor predictors of significant carotid disease.
Similarly, Wakefield and colleagues reviewed patients with
visual disturbances who had duplex examination performed
from June 1996 to December 2001.15 Patients (n  98)
had Duplex secondary to TMVL, HP, and RAO. Similar to
our results, only a small percentage of patients with HP
(2/36 carotid arteries), or RAO (2/18 carotid arteries) had
significant occlusive disease warranting CEA. These au-
thors concluded the patient who presented with visual signs
or symptoms may need to undergo a screening carotid
duplex examination (as a small percentage will have a
surgically correctable disease), but if the screening exami-
nation was normal then a follow-up duplex imaging was
not required.
Recent evidence indicates different mechanisms for
symptomatic vs asymptomatic retinal emboli. The former
are associated with ipsilateral carotid stenosis and middle
cerebral artery microembolic signals documented by trans-
cranial Doppler.16,17 Thus, TMVL may indicate a recent
ischemic event to the eye due to an embolic event from the
carotid bifurcation to the ophthalmic artery with a well
documented risk of future hemispheric or retinal stroke.
On the other hand, HP and RAO are often asymptomatic
lesions of unknown chronicity found on ocular examina-
tions and may represent a long standing prior event of a
small cholesterol embolus from any proximal source.
Limitations of our study include the retrospective na-
ture of the study. These patients were seen at a tertiary
referral hospital. Thus, other patients with ocular findings
and severe carotid pathology may have been treated at their
local centers without referral leading to a bias. The diag-
nostic testing and management of these patients was not
dictated and, thus, not uniform. Many patients were ini-
tially evaluated by their primary care doctor and referred to
an ophthalmologist. Only a minority were seen by a vascu-
lar surgeon. Lastly, there was inconsistent follow-up in this
patient population, which could have affected the long-
term results. The lack of carotid stenosis progression is
based on limited Duplex examinations and follow-up and
requires further confirmation. Despite these limitations,
this series represents the largest study of the natural historyof retinal arterial branch occlusions and Hollenhorst
plaques that we are aware of. Furthermore, the identifica-
tion of 130 patients from hospital diagnoses codes rather
than solely from referrals to the Department of Vascular
Surgery or departmental registries adds to the validity of
this study.
The impetus for our study was the prevailing notion
among both referring physicians and consulting surgeons
in our area that HP or RAO represented a vascular surgical
emergency. Apparently, variable management algorithms
for patients with this process seem widespread.18 Based on
our data, we conclude the presence of a HP or RAO is
associated with a low prevalence of extracranial cerebrovas-
cular disease that requires intervention. Furthermore, these
ocular findings, in the absence of carotid stenosis, are not
associated with a high risk for hemispheric neurological
events and represent a fairly innocuous event in contradis-
tinction to amaurosis fugax. Carotid artery therapy may be
needed but can be based on variables independent of the
ocular findings. Frequently, the decision to proceed with
surgical therapy will rest on the degree of carotid stenosis,
other neurological symptoms and comorbidities indepen-
dent of the ocular findings.
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